Pharmacological Class: Ionic Iodinated Contrast Media
Category: Radiologic Contrast Agents
Clinical Purpose: Enhancing visualization of internal structures during diagnostic imaging
Primary Routes: Intravenous (IV), intra-arterial, oral, rectal, intrathecal
Definition
Ionic iodinated contrast media are water-soluble, iodine-containing compounds used to enhance radiographic contrast in imaging procedures such as CT (computed tomography), angiography, urography, and fluoroscopy. They belong to a broader category of X-ray contrast agents, and are specifically distinguished by:
-
Iodine content – iodine has a high atomic number (Z=53), making it highly radio-opaque.
-
Ionic nature – they dissociate into charged particles (anions and cations) in solution, increasing osmolality.
-
High osmolality – older formulations are referred to as high-osmolality contrast media (HOCM).
Their ability to absorb X-rays improves the visibility of blood vessels, organs, and pathological structures, such as tumors, abscesses, or vascular malformations.
1. Chemical Structure and Classification
Ionic iodinated contrast agents are based on tri-iodinated benzoic acid derivatives. They are typically monomers or dimers that dissociate into anions and cations in aqueous solutions.
A. Monomeric Ionic Agents
-
Contain three iodine atoms per molecule.
-
Dissociate into two particles in solution.
-
Examples: Diatrizoate, Iothalamate
B. Dimeric Ionic Agents
-
Contain six iodine atoms per molecule.
-
Also dissociate, but contribute to lower osmolality than monomeric forms.
-
Rarely used due to high viscosity and cost.
2. Representative Examples of Ionic Iodinated Contrast Agents
| Generic Name | Brand Name(s) | Type | Primary Use |
|---|---|---|---|
| Diatrizoate | Gastrografin, Renografin | Monomeric, HOCM | CT, GI contrast, angiography, urography |
| Iothalamate | Conray | Monomeric, HOCM | Excretory urography, angiography |
| Metrizoate | Isopaque | Monomeric, HOCM | Cerebral angiography (obsolete) |
| Ioxitalamate | Telebrix | Monomeric, HOCM | Intravenous urography |
| Iodamide | Hyopaque | Dimeric, HOCM | IVP (legacy use) |
3. Osmolality and Ionic Behavior
-
Ionic agents dissociate in solution:
-
Example: Diatrizoate sodium splits into Na⁺ and an anion (tri-iodinated).
-
-
Osmolality:
-
Ranges 1,200–2,100 mOsm/kg, significantly higher than plasma (290 mOsm/kg).
-
-
High osmolality leads to:
-
Fluid shifts into the vascular system
-
Increased risk of adverse effects, especially in vulnerable patients
-
4. Mechanism of Action
-
Iodine atoms absorb X-rays due to high atomic number.
-
These agents accumulate in vascular compartments or specific organs (kidneys, liver, GI tract), attenuating X-ray beams.
-
Result: Radiopaque contrast that improves anatomical delineation in diagnostic images.
5. Clinical Applications
| Imaging Modality | Role of Ionic Iodinated Agents |
|---|---|
| CT scan (especially early) | Contrast-enhanced CT for detecting tumors, abscesses, vascular lesions |
| Intravenous urography (IVU) | Highlight renal excretion, ureters, and bladder |
| Angiography | Visualize arteries, veins, aneurysms |
| Hysterosalpingography (HSG) | Evaluate fallopian tube patency and uterine anatomy |
| Retrograde pyelography | Direct visualization of ureters from below |
| Oral GI contrast | Outline intestines when barium is contraindicated (e.g., perforation) |
| Myelography (rare now) | Previously used ionic agents to outline the spinal canal |
6. Adverse Effects and Toxicity
A. Common (Mild to Moderate)
-
Nausea and vomiting
-
Warm or flushing sensation
-
Headache
-
Metallic taste
-
Mild hypotension or tachycardia
B. Serious Reactions
-
Anaphylactoid reactions (non-IgE mediated): rash, bronchospasm, hypotension
-
Nephrotoxicity:
-
Contrast-induced acute kidney injury (CI-AKI), especially in patients with:
-
Diabetes
-
CKD
-
Volume depletion
-
-
-
Neurotoxicity:
-
Seizures, transient cortical blindness
-
Especially if administered intrathecally (not recommended)
-
C. Vascular and Cardiac
-
Bradycardia or arrhythmias (rare)
-
Vascular pain or thrombophlebitis
7. Risk Factors for Adverse Effects
-
Renal impairment (GFR < 60 mL/min)
-
Diabetes mellitus
-
Heart failure
-
Multiple myeloma
-
Volume depletion
-
Elderly patients
-
Previous reaction to contrast
-
Asthma or atopy
8. Prevention of Contrast Reactions
| Strategy | Description |
|---|---|
| Hydration | IV isotonic saline before and after contrast |
| Use of low-osmolality agents | Prefer non-ionic alternatives in high-risk patients |
| Pre-medication | Corticosteroids (e.g., prednisone 50 mg 13 hrs + 7 hrs pre-dose) |
| Avoid nephrotoxins | Withhold NSAIDs, aminoglycosides, metformin |
| Limit contrast dose | Especially in patients with low eGFR |
9. Comparison with Non-Ionic Agents
| Feature | Ionic (e.g., Diatrizoate) | Non-Ionic (e.g., Iohexol, Iopamidol) |
|---|---|---|
| Osmolality | High | Low to iso-osmolar |
| Ionic dissociation | Yes | No |
| Adverse reactions | Higher risk | Lower risk |
| Cost | Lower | Higher |
| Neurotoxicity (intrathecal) | Unsafe | Approved (specific agents) |
10. Contraindications
-
Previous severe hypersensitivity to iodinated contrast
-
Thyroid storm or uncontrolled hyperthyroidism
-
Decompensated heart failure (risk of fluid overload)
-
Renal failure without dialysis support
-
Use in intrathecal route (for most ionic agents)
-
Myasthenia gravis (caution—risk of exacerbation)
11. Drug Interactions
| Interacting Agent | Effect / Risk |
|---|---|
| Metformin | Lactic acidosis risk in renal impairment |
| Nephrotoxic drugs | Additive renal injury (e.g., aminoglycosides, NSAIDs) |
| Beta-blockers | May mask signs of anaphylaxis |
| Diuretics | Increased risk of volume depletion and nephropathy |
| Thyroid medications | Interference with uptake of radioactive iodine |
-
Withhold at time of procedure and 48 hours post-contrast if eGFR < 60 mL/min.
12. Elimination and Pharmacokinetics
-
Elimination: Renal (glomerular filtration)
-
Half-life: 1.5 to 2 hours (prolonged in CKD)
-
Not metabolized
-
Complete excretion in 24 hours with normal renal function
13. Special Populations
-
Pregnancy: Crosses placenta; category varies by region. Use only if necessary.
-
Lactation: Safe—minimal transfer to breast milk
-
Pediatrics: Dose-adjusted for weight. Risk of dehydration and renal toxicity
-
Elderly: Greater risk of AKI; use low osmolality agents when possible
14. Ionic Iodinated Agents Still in Use
Despite higher risks, ionic agents are:
-
Still used for GI imaging (oral/rectal routes) when barium is contraindicated
-
Available in developing countries due to lower cost
-
Phased out of most intravascular indications in favor of non-ionic counterparts
15. Regulatory and Clinical Notes
-
European Medicines Agency (EMA) and FDA discourage intrathecal use of ionic agents
-
Guidelines recommend using low- or iso-osmolar non-ionic agents in high-risk patients
-
Updated protocols favor pre-screening for renal function, especially with ionic formulations
No comments:
Post a Comment